Latest News & Features
Big Pharma
Novartis is set to acquire assets associated with Xiidra ((lifitegrast ophthalmic solution), a dry eye treatment, from Takeda. 10 May 2019
Americas
The US Court of Appeals for the Federal Circuit yesterday, May 8, rejected an appeal from Amgen in patent litigation relating to two Sandoz biosimilars. 9 May 2019
Americas
A generic version of Gilead’s Truvada will hit the market in 2020, a year earlier than expected. 9 May 2019
Biotechnology
Danish pharmaceutical company Lundbeck will acquire Abide Therapeutics, it has been announced. 8 May 2019
Biotechnology
A former scientist at Bayer CropScience shared confidential information with his new employer, which was used to develop commercial biopesticide products, according to a claim filed by the agricultural company. 8 May 2019
Big Pharma
One of Allergan’s patents has been invalidated after it was challenged by UK-based pharmaceutical companies Accord Healthcare and Aspire Pharma. 7 May 2019
Americas
British drugmaker Vectura has succeeded in its patent litigation against fellow UK pharmaceutical company GlaxoSmithKline over a series of drugs delivered through GSK’s ‘Ellipta’ dry powder inhaler. 7 May 2019
Asia
PepsiCo India is withdrawing its lawsuits against nine farmers in the Gujarat region who it accused of growing a protected variety of potato used to make the company’s ‘Lay’s’ brand of crisps. 7 May 2019
Big Pharma
The National Health Service, the UK’s government-run health system, has partnered with Gilead Sciences, Merck Sharp and Dohme and AbbVie to help eliminate hepatitis C in England. 3 May 2019
Biotechnology
A judge has dismissed actor Clint Eastwood’s motion to gain ownership over two diabetes patents currently assigned to Molecular Defenses Corporation. 2 May 2019